Uppsala BIO Signs First European Open Innovation Agreement With Roche
PR Newswire reports that Swedish life science initiative Uppsala BIO has formed a strategic partnering agreement with Roche, the world leading pharmaceuticals and diagnostics company, for Uppsala BIO’s open innovation program, BIO-X.The cooperation agreement links Uppsala BIO and BIO-X to Roche’s global innovation network on at least a three-year term. The agreement between Uppsala BIO and Roche is the result of Roche’s search for a European partner to its open innovation program EIN, Expanding the Innovation Network, and is the first of its kind in Europe.
Click here to read yhe full article.